FITLIFE BRANDS, INC. Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price
FITLIFE BRANDS, INC. (FTLF) had Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price of $4.52 per share as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Option, Exercise Price Range, Beginning of Period
us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 · last filed 2026-08-13
- 2026-06-30: Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price $4.52.
- 2026-03-31: Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price $3.97.
- 2025-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price $3.88.
- 2025-09-30: Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price $3.88.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2026-06-30 | $4.52 10-Q · filed 2026-08-13 |
| 2026-03-31 | $3.97 10-Q · filed 2026-05-14 |
| 2025-12-31 | $3.88 10-K · filed 2026-03-31 |
| 2025-09-30 | $3.88 10-Q · filed 2025-11-13 |
| 2025-06-30 | $3.73 10-Q · filed 2025-08-14 |
| 2025-03-31 | $3.75 10-Q · filed 2025-05-15 |
| 2024-12-31 | $3.74 10-K · filed 2025-03-27 |
| 2024-09-30 | $7.36 10-Q · filed 2024-11-14 |
| 2024-06-30 | $6.82 10-Q · filed 2024-08-14 |
| 2024-03-31 | $6.82 10-Q · filed 2024-05-14 |
| 2023-12-31 | $6.82 10-K · filed 2024-03-29 |
| 2023-09-30 | $2.92 10-Q · filed 2023-11-13 |
| 2023-06-30 | $3.09 10-Q · filed 2023-08-14 |
| 2023-03-31 | $3.09 10-Q · filed 2023-05-15 |
| 2022-12-31 | $3.09 10-K · filed 2023-03-24 |
| 2022-09-30 | $3.68 10-Q · filed 2022-11-10 |
| 2022-06-30 | $3.40 10-Q · filed 2022-10-14 |
| 2022-03-31 | $3.40 10-Q · filed 2022-10-14 |
| 2021-12-31 | $3.44 10-K · filed 2022-10-13 |
| 2021-09-30 | $12.44 10-Q · filed 2021-11-12 |
| 2021-06-30 | $12.44 10-Q · filed 2021-08-16 |
| 2021-03-31 | $12.64 10-Q · filed 2021-05-14 |
| 2020-12-31 | $10.05 10-K/A · filed 2022-10-13 |
| 2020-09-30 | $10.17 10-Q · filed 2020-11-12 |
| 2020-06-30 | $10.17 10-Q · filed 2020-08-13 |
| 2020-03-31 | $10.17 10-Q · filed 2020-05-15 |
| 2019-12-31 | $11.76 10-K · filed 2020-03-30 |
| 2019-09-30 | $11.76 10-Q · filed 2019-11-12 |
| 2019-06-30 | $12.05 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |